Drug Database
Back to search

Netherlands· NL-8766c222c00f

Tractocile 6,75 mg/ 0,9 ml oplossing voor injectie

A atosiban product containing atosibanacetaat, registered in Netherlands by Rechon Life Science AB. The same ATC class is registered in 14 of our 19 countries.

ATC G02CX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTractocile 6,75 mg/ 0,9 ml oplossing…ATCG02CX01REGISTER NO.NL-8766c222c00fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about atosibanacetaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Atosiban is registered in 14 of 19 countries.

Countries holding a registration under ATC G02CX01 (atosiban), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search atosiban products by name

Atosiban · ATC G02CX01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ATOSIBANACETAAT
Manufacturer
Rechon Life Science AB
Country
Netherlands (NL)
ATC code
G02CX01
ATC class
Atosiban
Defined daily dose
165 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/99/124

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Atosiban in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atosiban products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Atosiban Altan, Atosiban Ever Pharma
  • Belgium · Atosiban Ever Pharma
  • Bulgaria · Атозибан Ever Pharma
  • Czechia · Atosiban Avmc, Atosiban Ever Pharma
  • Germany · Atosiban Ever Pharma, Atosiban Ibisqus
  • Denmark · Atosiban Ever Pharma
  • Spain · Atosiban Altan Pharmaceuticals, S.A., Atosiban Ever Pharma
  • Finland · Atosiban Ever Pharma
  • France · Atosiban Altan, Atosiban Altan Pharmaceuticals, S.A.
  • United Kingdom (Northern Ireland) · Atosiban Ibigen
  • Greece · Atosiban Ever Pharma
  • Croatia · Atosiban Ever Pharma, Atosiban Makpharm
  • Iceland · Atosiban Sun, Tractocile
  • Italy · Atosiban Ever Pharma, Atosiban Ibisqus
  • Liechtenstein · Tractocile
  • Luxembourg · Atosiban Ever Pharma
  • Latvia · Atosiban Pharmidea
  • Norway · Atosiban Ever Pharma, Atosiban Sun
  • Poland · Atosiban Ever Pharma
  • Portugal · Atosiban Ever Pharma, Atosibano Altan
  • Sweden · Atosiban Accord, Atosiban Ever Pharma
  • Slovenia · Atoziban Ever Pharma
  • Slovakia · Atosiban Ardez

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a9f56da6-8eb6-488b-8443-bb1480170367
GET /v1/drugs/a9f56da6-8eb6-488b-8443-bb1480170367?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tractocile-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Atosiban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70490",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ATOSIBANACETAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2000/01/20",
  "procedure_number": "EMEA/H/C/000253",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/99/124",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about atosiban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console